OneMedNet, a software developer, agreed to go public via a SPAC merger with Data Knights Acquisition, a special purposes acquisition company, in a $317m. "Today's announcement is a tremendous milestone for OneMedNet. Since joining the board of OneMedNet in 2021, and most recently assuming the CEO role, my focus has been on readying the Company for its journey as a publicly traded entity. This merger is the next, necessary step in our incredible journey and through this transaction we will be further positioned to fuel our growth trajectory. OneMedNet is uniquely positioned within the clinical trial and clinical research industries, which together represent a $400bn market. Our runway is limitless and this merger with Data Knights is just the beginning," Paul Casey, OneMedNet CEO.